NDC 70436-151
Arformoterol Tartrate Inhalation
Arformoterol Tartrate Inhalation
Arformoterol Tartrate Inhalation is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is Arformoterol Tartrate.
| Product ID | 70436-151_27a1ba65-5029-462a-8e6e-5ac1056e6c72 |
| NDC | 70436-151 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Arformoterol Tartrate Inhalation |
| Generic Name | Arformoterol Tartrate Inhalation |
| Dosage Form | Solution |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2021-06-22 |
| Marketing Category | ANDA / |
| Application Number | ANDA213762 |
| Labeler Name | Slate Run Pharmaceuticals |
| Substance Name | ARFORMOTEROL TARTRATE |
| Active Ingredient Strength | 15 ug/2mL |
| Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |